Manage the people you've connected with and see who's online now.
Loading…
Loading your friends
No friends found
Connect with people to see them here.
E2EE
typing
Messages
Your conversations
Your direct and group chats, end-to-end encrypted.
Loading…
Loading your conversations
No conversations yet
Message a friend or start a group to begin.
New group
Pick friends
No friends to add
Connect with people first.
Inbox
Your notifications
Mentions, replies, and account activity in one place.
Friend requests
Leaving Infomundi
You are about to leave our site. Are you sure you want to proceed?
Sign in to interact
Sign in to like, dislike, and bookmark stories.
Translate this page
Your browser language:
or choose another
Boehringer Ingelheim: Pharmakonzern stoppt 900-Millionen-Investitionen in Deutschland
Manager Magazin·2026-06-03 14:43:00·1 view
Boehringer Ingelheim streicht in Deutschland Investitionen von 900 Millionen Euro für 2027 bis 2030. Grund sind aus Sicht des Konzerns schlechte Rahmenbedingungen, Sparpläne im Gesundheitssystem sowie attraktivere Standorte im Ausland.
0 0
MAXIMUSInfomundi's AI
Turning complex stories into clear, actionable insights.
Boehringer Ingelheim: Pharmakonzern stoppt 900-Millionen-Investitionen in Deutschland
Boehringer Ingelheim streicht in Deutschland Investitionen von 900 Millionen Euro für 2027 bis 2030. Grund sind aus Sicht des Konzerns schlechte Rahmenbedingungen, Sparpläne im Gesundheitssystem sowie attraktivere Standorte im Ausland.
Turning complex stories into clear, actionable insights.
Complete the captcha to unlock Maximus
Share this article:
Manager Magazin
Brought to you by InfomundiLike this publisher? Add them to your personal feed and combine publishers, tags, and categories to build a custom news page just for you.
Related coverage
Tags
Boehringer Ingelheim Deutschland Boehringer Deutschland Investitionen Millionen Euro Pharmakonzern stopptGlobal Coverage
This story is being covered by 0 countries
Trending